跳转到主要内容
首页

Dedicated to discovery

  • 关于 ELGA
    • 关于 ELGA
    • 招贤纳士
    • 活动
  • 支持
    • 实验室规划
  • 联系信息
  • EN
  • DE
  • ES
  • FR
  • IT
  • PT
  • JA
  • EN-US
首页
  • 产品
    • PURELAB
      • PURELAB® Flex
      • PURELAB® Quest
      • PURELAB® Pharma Compliance
      • PURELAB® Chorus 1 Complete
      • PURELAB® Chorus 1
      • PURELAB® Chorus 2
      • PURELAB® Chorus 3
      • PURELAB® Chorus 2 +
    • CENTRA
      • CENTRA® R60/120
      • CENTRA® R200
      • CENTRA® RDS
    • MEDICA
      • MEDICA® 7/15
      • MEDICA® Pro-R & Pro-RE
      • MEDICA® R200
      • MEDICA® EDI 15/30
      • MEDICA® Pro-LPS
      • MEDICA® Pro EDI 60/120
      • MEDICA® BIOX
      • Hubgrade
    • BIOPURE
      • BIOPURE® 300/600
    • PURENERGY 30
    • ELGA 全产品系列
  • 应用
    • 一般实验室用水要求
    • 临床生物化学
    • 免疫化学
    • 分光光度测定法:
    • 原子光谱分析法
    • 微生物分析
    • 气相色谱分析法
    • 液相色谱
      • High Performance Liquid Chromatography
    • 电化学
    • 细胞培养
    • 质谱分析法
    • 遗传学
    • 高效液相色谱 (HPLC)
  • 水纯化技术
    • PureSure
    • 反渗透法
    • 活性碳
    • 电去离子法
    • 离子交换法
    • 紫外线照射法
    • 过滤
  • 水中杂质
    • 微生物和细菌
    • 微粒
    • 无机化合物
    • 有机化合物
    • 溶解气体
  • 知识
    • BROSCHÜREN
    • 博客
    • 案例分析
    • 超纯水
    • 白皮书
  • 如何购买?
  • 联系信息
Home
  • 联系信息
  • 产品
    • PURELAB
      • PURELAB® Flex
      • PURELAB® Quest
      • PURELAB® Pharma Compliance
      • PURELAB® Chorus 1 Complete
      • PURELAB® Chorus 1
      • PURELAB® Chorus 2
      • PURELAB® Chorus 3
      • PURELAB® Chorus 2 +
    • CENTRA
      • CENTRA® R60/120
      • CENTRA® R200
      • CENTRA® RDS
    • MEDICA
      • MEDICA® 7/15
      • MEDICA® Pro-R & Pro-RE
      • MEDICA® R200
      • MEDICA® EDI 15/30
      • MEDICA® Pro-LPS
      • MEDICA® Pro EDI 60/120
      • MEDICA® BIOX
      • Hubgrade
    • BIOPURE
      • BIOPURE® 300/600
    • PURENERGY 30
    • ELGA 全产品系列
  • 应用
    • 一般实验室用水要求
    • 临床生物化学
    • 免疫化学
    • 分光光度测定法:
    • 原子光谱分析法
    • 微生物分析
    • 气相色谱分析法
    • 液相色谱
      • High Performance Liquid Chromatography
    • 电化学
    • 细胞培养
    • 质谱分析法
    • 遗传学
    • 高效液相色谱 (HPLC)
  • 水纯化技术
    • PureSure
    • 反渗透法
    • 活性碳
    • 电去离子法
    • 离子交换法
    • 紫外线照射法
    • 过滤
  • 水中杂质
    • 微生物和细菌
    • 微粒
    • 无机化合物
    • 有机化合物
    • 溶解气体
  • 知识
    • BROSCHÜREN
    • 博客
    • 案例分析
    • 超纯水
    • 白皮书
  • 如何购买?
  • 联系信息
  • 关于 ELGA
    • 关于 ELGA
    • 招贤纳士
    • 活动
  • 支持
    • 实验室规划
  • 联系信息
  • EN
  • DE
  • ES
  • FR
  • IT
  • PT
  • JA
  • EN-US
  • 隐私政策
  • 条款和条件
  • 全球法律合规
  • 专利
  • Trademarks
  • 页面操作员
  • Studying the role of lipids in Alzheimer’s disease
Life Science Results
Analytical Chemistry

Studying the role of lipids in Alzheimer’s disease

12 9月 2022
- by Dr Alison Halliday

Studying the role of lipids in Alzheimer's disease

Recent advances in lipidomics – the comprehensive analysis of the lipids in tissues and body fluids – offer exciting new opportunities to explore the biology of Alzheimer’s disease. Over 55 million people are estimated to be living with dementia worldwide – and that number is set to double every 20 years as the population ages. By 2050, it is predicted this figure will have jumped to 139 million.
 


Alzheimer’s disease (AD) is the most common type of dementia. A person with AD will experience progressive memory loss and changes to their personality and behaviour. The major pathological hallmarks in the AD brain are amyloid plaques, consisting of β-amyloid peptide (Aβ) and neurofibrillary tangles.

The amyloid hypothesis, first proposed in the early 1990s, suggested that certain types of Aβ start to clump together to form plaques that collect between neurons and disrupt cell function. One particular form, called Aβ1-42, is thought to be especially toxic. But the exact mechanism for how Aβ determines brain dysfunction in AD remains unclear.

Lipids, as the basic component of cell membranes, play an important role in healthy brain function. There is mounting evidence to suggest that altered lipid metabolism contributes to AD pathogenesis. Developing ways to monitor cell lipid profile changes in response to Aβ exposure could help uncover new insight into the biology of AD – and identify potential new biomarkers for the disease.

Lipid profiling

In a new study, published in the Journal of Pharmaceutical and Biomedical Analysis, a team of researchers set out to evaluate the toxic effects of Aβ1-42 on cultured neuronal cells using lipidomics.1

The team treated differentiated human neuroblastoma-derived SH-SY5Y cells (which are widely used as a model for neurodegenerative diseases) with increasing concentrations of Aβ1-42 at different times. Following lipid extraction, they then performed liquid-chromatography mass spectrometry (LC-MS) – comparing data between treated and untreated cells to identify and relatively quantify altered species in various lipid classes.

The method was found suitable to underline some peculiar lipid alterations that might be correlated to exposure to different Aβ1-42 aggregation species. Encouragingly, some of the results overlapped with those obtained in other studies through lipidomic analysis on cerebrospinal fluid and plasma of AD patients.

The researchers used ultrapure water generated from an ELGA PURELAB® laboratory water purification system, minimising the risk of adding potential contaminants that could affect their results.

Research tool

After further validation, this novel method could provide a way to identify potential lipid-based biomarkers for research in clinical samples of AD patients. In the meantime, it can support the investigation of cellular response mechanisms to amyloid toxic stimuli and contribute to new hypotheses about the role of lipids in the disease.

This pilot work will guide future study designs for advanced investigations to validate the role of Aβ peptides on the lipidome of neuronal cells – and for the discovery of lipid biomarkers that could ultimately be useful for AD diagnosis, prognosis prediction, or monitoring therapeutic response in biological samples.

Why choose ELGA LabWater

At ELGA LabWater, our expert engineers, chemists and scientists are at the forefront of technological innovation. They continue to introduce game-changing features to the lab water market.

 

Reference:

  1. Davani L, et al. Aβ1-42 peptide toxicity on neuronal cells: A lipidomic study. J Pharm Biomed Anal. 2022;219:114876 doi: 10.1016/j.jpba.2022.114876.



Dr Alison Halliday

After completing an undergraduate degree in Biochemistry & Genetics at Sheffield University, Alison was awarded a PhD in Human Molecular Genetics at the University of Newcastle. She carried out five years as a Senior Postdoctoral Research Fellow at UCL, investigating the genes involved in childhood obesity syndrome. Moving into science communications, she spent ten years at Cancer Research UK engaging the public about the charity’s work. She now specialises in writing about research across the life sciences, medicine and health.





 

  • 留言咨询
  • 获取报价
  • 预订演示
  • 联系获认证的合作伙伴

留言咨询

在 ELGA LABWATER,我们希望能够为您提供有关我们实验室水纯化产品的精彩优惠和新闻动态。 我们将使用您提供的信息来预测您可能会感兴趣的内容。 我们会慎重处理您的数据,您可在此查阅我们的隐私政策。

ELGA LABWATER 的所有合作伙伴均已通过我们的审慎审核和认证。 为了对您的问题或查询进行回复,我们可能将您的联系详情转发给获认证的合作伙伴,由他们直接与您联系。 您可在此查看我们的获认证业务合作伙伴名单。

如果您希望接收来自 ELGA 及我们获认证合作伙伴的最新动态,请勾选下框: 在此.

是,我希望 ELGA LabWater 及其获认证合作伙伴基于我的联系详情为我发送其最新动态

获取报价

At ELGA LabWater, we have exciting offers and news about our products and services that we hope you’d like to hear about. We will use your information to predict what you might be interested in. We will treat your data with respect and you can find the details in our Privacy Policy.

ELGA LabWater works with a network of Approved Partners. In order to answer your questions or enquiries, we may pass your contact details to an Approved Partner, who may contact you directly. 

I'd like to receive updates from ELGA LabWater & ELGA Approved Partners based on my details.

预订演示

At ELGA LabWater, we have exciting offers and news about our products and services that we hope you’d like to hear about. We will use your information to predict what you might be interested in. We will treat your data with respect and you can find the details in our Privacy Policy.

ELGA LabWater works with a network of Approved Partners. In order to answer your questions or enquiries, we may pass your contact details to an Approved Partner, who may contact you directly. 

I'd like to receive updates from ELGA LabWater & ELGA Approved Partners based on my details.

Call us

Can't find what you are looking for?

Support Number
+44 (0)20 3567 7300
United Kingdom Sales
+44 (0)1628 879 704
United States of America Sales
+1 877-315-3542
France Sales
+33 1 40 83 65 00
China Sales
+86 400-616-8882

 

Elga LabWater 总部

ELGA Labwater英国总部

VWS(UK)Ltd.

Lane End Business Park,Lane End,High Wycombe

HP14 3BY,United Kingdom

ELGA Labwater中国总部

威立雅水处理技术(上海)有限公司

地址 : 上海市浦东新区张东路1761号5号楼
电话 : 021 - 38172288
传真 : 021 - 38172289
邮编 : 201210

案例研究

  • 雅培诊断
  • DASA 医学诊断
  • NeoDIN 医学研究所
  • 北斯塔福德郡 NHS 信托大学医院
  • Olsberg 职业技术学院

学习资源

  • 了解超纯水
  • 白皮书
  • 水纯化技术
  • 实验室应用
  • 水中杂质
  • Latest Blog
  • Water Purity - Different Types of Pure Water
  • What is Clinical Laboratory Reagent Water (CLSI)?
  • What is Total Organic Carbon (TOC)?

© VWS (UK) Ltd. 以 ELGA®LabWater 的名义经营业务。2024- 保留所有权利
ELGA 是 Veolia 旗下全球实验室用水品牌。

  • 隐私政策
  • 条款和条件
  • 全球法律合规
  • 专利
  • Trademarks
  • 页面操作员
  • 语言
    • Deutsch
    • English
    • Español
    • Français
    • Italiano
    • Português
    • 日本語
    • 中文
  • Veolia 其他站点
    • Veolia
    • Veolia Foundation
    • Veolia Water Technologies
Elga Veolia
TOP

© 2017 ELGA Veolia